ArticleTrials2022

Efficacy and safety of Dengyinnaotong Capsule in patients with Cognitive impairment caused by cerebral Small Vessel Disease: study protocol of a multicenter, randomized, open-label, controlled trial (De-CSVD trial).

Yan-Xia Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.